153 related articles for article (PubMed ID: 27890462)
1. Radiation pneumonitis following hepatic yttrium-90 radioembolization.
Castro HM; Wainstein EJ; Maritano Furcada J
Arch Bronconeumol; 2017 Apr; 53(4):216-217. PubMed ID: 27890462
[No Abstract] [Full Text] [Related]
2. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review.
Wright CL; Werner JD; Tran JM; Gates VL; Rikabi AA; Shah MH; Salem R
J Vasc Interv Radiol; 2012 May; 23(5):669-74. PubMed ID: 22525023
[TBL] [Abstract][Full Text] [Related]
3. Segmental Pneumonitis after Radioembolization.
Jaureguizar JIB; Sancho L; Páramo M; Rodríguez-Fraile M; Chopitea A; Benito A; Iñarrairaegui M; Sangro B
J Vasc Interv Radiol; 2018 Sep; 29(9):1305-1306. PubMed ID: 30146206
[No Abstract] [Full Text] [Related]
4. Lung Dose Measured on Postradioembolization
Stella M; van Rooij R; Lam MGEH; de Jong HWAM; Braat AJAT
J Nucl Med; 2022 Jul; 63(7):1075-1080. PubMed ID: 34772794
[TBL] [Abstract][Full Text] [Related]
5. A surreptitious trip to the lungs.
Courtright KR; Kotloff RM
Ann Am Thorac Soc; 2014 Jan; 11(1):137-40. PubMed ID: 24460448
[No Abstract] [Full Text] [Related]
6. [Radioembolization with (90)Y-microspheres for liver tumors].
Rodríguez-Fraile M; Iñarrairaegui M
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062
[No Abstract] [Full Text] [Related]
7. Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings.
Lin M
AJR Am J Roentgenol; 1994 Jun; 162(6):1300-2. PubMed ID: 8191985
[No Abstract] [Full Text] [Related]
8. Microspheres for radioembolization of liver malignancies.
Vente MA; Zonnenberg BA; Nijsen JF
Expert Rev Med Devices; 2010 Sep; 7(5):581-3. PubMed ID: 20822380
[No Abstract] [Full Text] [Related]
9. Outpatient Yttrium-90 microsphere radioembolization: assessment of radiation safety and quantification of post-treatment adverse events causing hospitalization.
Aberle S; Kenkel D; Becker AS; Puippe G; Burger I; Schaefer N; Pfammatter T
Radiol Med; 2020 Oct; 125(10):971-980. PubMed ID: 32270335
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 Radioembolization for Breast Cancer Liver Metastases.
Gordon AC; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1316-1319. PubMed ID: 27566423
[No Abstract] [Full Text] [Related]
11. Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
J Gastroenterol Hepatol; 2017 Sep; 32(9):1617-1623. PubMed ID: 28132407
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.
Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828
[No Abstract] [Full Text] [Related]
14. [Arterial radioembolization of malignant liver tumors by yttrium-90 microspheres].
Tarazov PG
Vopr Onkol; 2013; 59(4):428-34. PubMed ID: 24032215
[No Abstract] [Full Text] [Related]
15. Combination Ipsilateral Lobar and Segmental Radioembolization Using Glass Yttrium-90 Microspheres for Treatment of Multifocal Hepatic Malignancies.
Arslan B; Padela MT; Madassery S; Masrani A; Tasse J; Supanich M; Ahmed O
J Vasc Interv Radiol; 2018 Aug; 29(8):1110-1116. PubMed ID: 30055781
[TBL] [Abstract][Full Text] [Related]
16. Survival after accidental extrahepatic distribution of Y90 microspheres to the mesentery during a radioembolization procedure.
Sabet A; Ahmadzadehfar H; Schäfer N; Wilhelm K; Schüller H; Ezziddin S
Cardiovasc Intervent Radiol; 2012 Aug; 35(4):954-7. PubMed ID: 22006030
[TBL] [Abstract][Full Text] [Related]
17. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
[TBL] [Abstract][Full Text] [Related]
18. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
[TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 Radioembolization After Local Hepatic Therapy: How Prior Treatments Impact Patient Selection, Dosing, and Toxicity.
Kessler J; Park JJ
Tech Vasc Interv Radiol; 2019 Jun; 22(2):112-116. PubMed ID: 31079707
[TBL] [Abstract][Full Text] [Related]
20. Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings.
Parakh S; Gananadha S; Allen R; Yip D
Asian J Surg; 2016 Jul; 39(3):144-8. PubMed ID: 26116405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
